Pseudomonas

Results: 691



#Item
1Involvement of the Lon Protease in the SOS Response Triggered by Ciprofloxacin in Pseudomonas aeruginosa PAO1 Elena B. M. Breidenstein, Manjeet Bains and Robert E. W. Hancock Antimicrob. Agents Chemother. 2012, 56(6):287

Involvement of the Lon Protease in the SOS Response Triggered by Ciprofloxacin in Pseudomonas aeruginosa PAO1 Elena B. M. Breidenstein, Manjeet Bains and Robert E. W. Hancock Antimicrob. Agents Chemother. 2012, 56(6):287

Add to Reading List

Source URL: cmdr.ubc.ca

Language: English - Date: 2016-12-15 19:09:35
    2Amy T. Y. Yeung, Alicia Parayno and Robert E. W. HancockMucin Promotes Rapid Surface Motility in Pseudomonas aeruginosa. mBio 3(3): . doi:mBioUpdated information and services can be found at:

    Amy T. Y. Yeung, Alicia Parayno and Robert E. W. HancockMucin Promotes Rapid Surface Motility in Pseudomonas aeruginosa. mBio 3(3): . doi:mBioUpdated information and services can be found at:

    Add to Reading List

    Source URL: cmdr.ubc.ca

    Language: English - Date: 2016-12-15 19:09:32
      3Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

      Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

      Add to Reading List

      Source URL: visterrainc.com

      Language: English - Date: 2017-10-03 19:39:52
        4A novel small RNA is important for biofilm formation and pathogenicity in Pseudomonas aeruginosa

        A novel small RNA is important for biofilm formation and pathogenicity in Pseudomonas aeruginosa

        Add to Reading List

        Source URL: cmdr.ubc.ca

        Language: English - Date: 2017-08-29 13:25:35
          5articles Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen C. K. Stover*, X. Q. Pham², A. L. Erwin*, S. D. Mizoguchi*, P. Warrener*, M. J. Hickey*, F.S. L. Brinkman³, W. O. Hufnagle*,

          articles Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen C. K. Stover*, X. Q. Pham², A. L. Erwin*, S. D. Mizoguchi*, P. Warrener*, M. J. Hickey*, F.S. L. Brinkman³, W. O. Hufnagle*,

          Add to Reading List

          Source URL: cmdr.ubc.ca

          Language: English - Date: 2016-12-15 19:09:07
            6Medicinsk Radiofysik 30. Pseudomonas aeruginosa utilizes its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii. Hadi Abd, Amir Saeed, Bengt Wretlind, Gunnar Sandström. 31. Experimental i

            Medicinsk Radiofysik 30. Pseudomonas aeruginosa utilizes its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii. Hadi Abd, Amir Saeed, Bengt Wretlind, Gunnar Sandström. 31. Experimental i

            Add to Reading List

            Source URL: www.radiofysik.org

            Language: Swedish - Date: 2014-12-26 05:00:48
              7Epithelix in vitro Solutions for Respiratory Diseases and Chemical Testing In vitro evaluation of novel antibiotics against Pseudomonas aeruginosa infection on Human Airway Epithelia

              Epithelix in vitro Solutions for Respiratory Diseases and Chemical Testing In vitro evaluation of novel antibiotics against Pseudomonas aeruginosa infection on Human Airway Epithelia

              Add to Reading List

              Source URL: www.epithelix.com

              Language: English - Date: 2017-11-27 05:16:27
                8Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

                Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

                Add to Reading List

                Source URL: www.visterrainc.com

                Language: English - Date: 2017-10-03 19:39:52
                  9CRapid Quantitation and Identification of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii In Bronchoalveolar Lavage Fluid Steve Metzger

                  CRapid Quantitation and Identification of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii In Bronchoalveolar Lavage Fluid Steve Metzger

                  Add to Reading List

                  Source URL: acceleratediagnostics.com

                  - Date: 2013-03-07 16:35:46
                    10Press release_Polyphor Ltd_POL7080 Phase I results Release (March 4, 2013) Polyphor reports successful Phase I results for its Pseudomonas selective antibiotic POL7080 Allschwil, Switzerland, March 4, Polyphor Ltd

                    Press release_Polyphor Ltd_POL7080 Phase I results Release (March 4, 2013) Polyphor reports successful Phase I results for its Pseudomonas selective antibiotic POL7080 Allschwil, Switzerland, March 4, Polyphor Ltd

                    Add to Reading List

                    Source URL: www.polyphor.com

                    - Date: 2013-11-01 12:12:29